MS-PEG10-THP is widely used in bioconjugation and drug delivery systems due to its ability to enhance solubility, stability, and bioavailability of therapeutic compounds. It serves as a linker in the development of antibody-drug conjugates (ADCs), enabling targeted delivery of drugs to specific cells while minimizing off-target effects. The THP (tetrahydropyran) group provides a protective functionality, which can be selectively removed under specific conditions, allowing controlled release of the active drug. Additionally, its PEG (polyethylene glycol) spacer improves biocompatibility and reduces immunogenicity, making it suitable for use in various biomedical applications, including cancer therapy and protein modification.